Researchers say they’ve located a “kill switch” that can trigger the death of cancer cells. Scientists at the UC Davis Comprehensive Cancer Center in Sacramento, California, have identified a protein on the CD95 receptor that can “program” cancer cells to die, as detailed in a study published in the journal …
Read More »
A common chemical that is widespread in the U.S. has been linked to an increased risk of Parkinson’s disease, researchers say. In a recent study published in the journal Neurology, researchers found a “small but measurable increase in Parkinson’s risk” linked to trichloroethylene (TCE), which has been found to spread …
Read More »
An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom noted remarkable outcomes. Larry Williams, a trial participant based in Philadelphia, Pennsylvania, shared with Fox News Digital …
Read More »
As the global population ages, the prevalence of Parkinson’s continues to rise, with an estimated 25 million people expected to be living with the neurological disease by 2050. The incurable progressive disorder affects motor abilities and other nervous system functions, typically causing stiffness, tremors, balance problems and slowed movement, along …
Read More »